Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of sertindole vs olanzapine or risperidone on cognitive and fMRI measures in chronic schizophrenia
2008-001128-30Phase 4Completed
- Sponsor
- Semmelweis University Department of Psychiatry and Psychotherapy
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sertindole, olanzapine and risperidone in schizophrenia (3 arms), sponsored by Semmelweis University Department of Psychiatry and Psychotherapy. Primary endpoints: Change in preattentive cognitive function (Prepulse Inhibition, PPI) and Change in attention-dependent cognitive function (Continuous Performance Task, CPT). Started Mar 2008; status: completed.
02
Drugs
sertindoleolanzapinerisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2008-001128-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001128-30.